By using this site, you agree to the Privacy Policy and Terms of Use.
Accept
Medical Information, Documents, News - TheMediTary.Com Logo Medical Information, Documents, News - TheMediTary.Com Logo

TheMediTary.Com

Medical Information, Documents, News - TheMediTary.Com

  • Home
  • News
  • Drugs
  • Drugs A-Z
  • Medical Answers
  • About Us
  • Contact
Medical Information, Documents, News - TheMediTary.Com Logo Medical Information, Documents, News - TheMediTary.Com Logo
Search Drugs
  • Drugs
    • Latest Drugs
    • Drugs A-Z
    • Medical Answers
  • News
    • FDA Alerts
    • Medical News
    • Health
    • Consumer Updates
    • Children's Health
  • More TheMediTary.Com
    • About Us
    • Contact
Follow US
Home > Drugs > Antidotes > Antizol > Fomepizole Dosage
Antidotes
https://themeditary.com/dosage-information/fomepizole-dosage-5380.html

Fomepizole Dosage

Drug Detail:Antizol (Fomepizole [ foe-mep-i-zole ])

Drug Class: Antidotes

Contents
Uses Warnings Before Taking Dosage Side effects Interactions

Usual Adult Dose for Methanol Poisoning

Patients not requiring hemodialysis:

Initial dose: 15 mg/kg, IV, followed by 10 mg/kg, IV every 12 hours for 4 doses
Maintenance dose: 15 mg/kg, IV, every 12 hours, until ethylene glycol/methanol concentrations are undetectable, or below 20 mg/dL and patient is asymptomatic with normal pH

Comments:

  • Begin treatment immediately upon suspicion of ethylene glycol or methanol ingestion.
  • Consider concomitant dialysis for renal failure, metabolic acidosis, or ethylene glycol/methanol concentrations of 50 mg/dL or higher.
  • Discontinue this drug when ethylene glycol/methanol concentrations are undetectable, or below 20 mg/dL and patient is asymptomatic with normal pH.

Usual Adult Dose for Ethylene Glycol Poisoning

Patients not requiring hemodialysis:

Initial dose: 15 mg/kg, IV, followed by 10 mg/kg, IV every 12 hours for 4 doses
Maintenance dose: 15 mg/kg, IV, every 12 hours, until ethylene glycol/methanol concentrations are undetectable, or below 20 mg/dL and patient is asymptomatic with normal pH

Comments:

  • Begin treatment immediately upon suspicion of ethylene glycol or methanol ingestion.
  • Consider concomitant dialysis for renal failure, metabolic acidosis, or ethylene glycol/methanol concentrations of 50 mg/dL or higher.
  • Discontinue this drug when ethylene glycol/methanol concentrations are undetectable, or below 20 mg/dL and patient is asymptomatic with normal pH.

Usual Pediatric Dose for Methanol Poisoning

Not approved for pediatric use, however safe and effective use in pediatrics has been reported in medical literature.

Patients not requiring hemodialysis:

Initial dose: 15 mg/kg, slow IV over 30 minutes, followed by 10 mg/kg, IV every 12 hours for 4 doses
Maintenance dose: 15 mg/kg, IV, every 12 hours, until ethylene glycol/methanol concentrations are undetectable, or below 20 mg/dL and patient is asymptomatic with normal pH

Comments:

  • All doses should be administered slow IV over 30 minutes.
  • Begin treatment immediately upon suspicion of ethylene glycol or methanol ingestion.
  • Consider concomitant dialysis for renal failure, metabolic acidosis, or ethylene glycol/methanol concentrations of 50 mg/dL or higher.
  • Discontinue this drug when ethylene glycol/methanol concentrations are undetectable, or below 20 mg/dL and patient is asymptomatic with normal pH.

Usual Pediatric Dose for Ethylene Glycol Poisoning

Not approved for pediatric use, however safe and effective use in pediatrics has been reported in medical literature.

Patients not requiring hemodialysis:

Initial dose: 15 mg/kg, slow IV over 30 minutes, followed by 10 mg/kg, IV every 12 hours for 4 doses
Maintenance dose: 15 mg/kg, IV, every 12 hours, until ethylene glycol/methanol concentrations are undetectable, or below 20 mg/dL and patient is asymptomatic with normal pH

Comments:

  • All doses should be administered slow IV over 30 minutes.
  • Begin treatment immediately upon suspicion of ethylene glycol or methanol ingestion.
  • Consider concomitant dialysis for renal failure, metabolic acidosis, or ethylene glycol/methanol concentrations of 50 mg/dL or higher.
  • Discontinue this drug when ethylene glycol/methanol concentrations are undetectable, or below 20 mg/dL and patient is asymptomatic with normal pH.

Renal Dose Adjustments

Data not available

Liver Dose Adjustments

Data not available

Precautions

Safety and efficacy have not been established in patients younger than 18 years.

Consult WARNINGS section for additional precautions.

Dialysis

Patients requiring hemodialysis: (see usual adult dosing)
Dose at the beginning of hemodialysis:
Less than 6 hours since last dose: Do not administer dose
6 hours or more since last dose: Administer next scheduled dose

Dose during hemodialysis: Administer every 4 hours or as a continuous infusion 1 to 1.5 mg/kg/hour.

Dose at the time hemodialysis is completed:
Less than 1 hour between last dose and the end of hemodialysis: Do not administer dose at the end of hemodialysis.
1 to 3 hours between last dose and the end of hemodialysis: Administer half of next scheduled dose.
Greater than 3 hours between last dose and end of hemodialysis: Administer next scheduled dose.

Maintenance dose off hemodialysis: Give next scheduled dose 12 hours from last dose administered.

Peritoneal dialysis: Data not available

Comments:

  • All doses should be administered slow IV over 30 minutes.
  • Begin treatment immediately upon suspicion of ethylene glycol or methanol ingestion.
  • Consider concomitant dialysis for renal failure, metabolic acidosis, or ethylene glycol/methanol concentrations of 50 mg/dL or higher.
  • Discontinue this drug when ethylene glycol/methanol concentrations are undetectable, or below 20 mg/dL and patient is asymptomatic with normal pH.

Other Comments

Administration advice:

  • Infuse over 30 minutes.

Storage requirements:
  • Store at controlled room temperature.

Reconstitution/preparation techniques:
  • This drug solidifies at temperatures less than 25C (77F).
  • If drug has solidified, liquefy by running vial under warm water or holding in the hand.
  • Solidification does not affect efficacy, safety, or stability.
  • Mix dose in at least 100 mL of 0.9% sodium chloride or 5% dextrose for injection; mix well.
  • Diluted drug is stable for up to 24 hours.
Share this Article
Latest News
Medical News

Seed oils: Omega-6 fatty acids may lower diabetes, heart disease risk

Jun 01, 2025
Type 2 diabetes: Sugary drinks may significantly raise risk
COVID-19: Who do the new vaccine guideline changes affect?
Vitamin D supplements may help slow down aging by 3 years
Aging: Exercise timing, consistency can affect heart and lung fitness
Heart health: Exercise not enough to offset effects of poor sleep
Related Drugs
Fidanacogene Elaparvovec
Cerave Anti-Itch
Centrum Adult
Crovalimab
Cyltezo Prefilled Syringe
Zepbound Pen
Mylanta One
Uretron Ds
Medihoney Wound And Burn Dressing
Lidotrode

Other drugs

Name Drug Class Updated
Fidanacogene Elaparvovec Drugs 03-Oct-2024
Cerave Anti-Itch Drugs 02-Oct-2024
Centrum Adult Drugs 02-Oct-2024
Crovalimab Drugs 02-Oct-2024
Cyltezo Prefilled Syringe Drugs 01-Oct-2024
Zepbound Pen Drugs 30-Sep-2024
Mylanta One Drugs 27-Sep-2024
Uretron Ds Drugs 27-Sep-2024
Medihoney Wound And Burn Dressing Drugs 26-Sep-2024
Lidotrode Drugs 26-Sep-2024
Libervant Drugs 26-Sep-2024
Moderna Covid-19 Drugs 25-Sep-2024
Beqvez Drugs 24-Sep-2024
Beqvez Drugs 24-Sep-2024
Beqvez Drugs 24-Sep-2024

Categories

  • FDA Alerts
  • Medical News
  • Health
  • Consumer Updates
  • Children's Health

About US

Welcome to TheMediTary.Com

Our website provides reliable and up-to-date information on various medical topics. We empower individuals to take charge of their health by simplifying complex medical jargon and providing practical tips and advice. We prioritize the privacy and confidentiality of our users and welcome feedback to improve our services.

Website use data of FDA and other sources

DMCA.com Protection Status Truste Protection Status Trust Mark Protection Status
HONcode logo We comply with the HONcode standard for trustworthy health information.
Quick Link
  • About Us
  • Contact Us
  • Editorial Policy
  • Privacy Policy
  • Accessibility Policy
  • Terms & Conditions
  • Disclaimer
  • DMCA
  • Do Not Sell My Personal Information
  • Sitemap
  • Care Notes
  • Health Guide
  • Professional
Drugs
  • New Drugs
  • Medical Answers
  • Drugs A-Z
  • Drug Classes
  • Drug Dosage
  • Pill Identifier
  • Consumer Infor
  • Side Effects
  • Inactive Ingredients
  • Pregnancy Warnings
  • Patient Tips
  • Treatments
News
  • Latest News
  • FDA Alerts
  • Medical News
  • Health
  • Consumer Updates
  • Children's Health
Find US
  • Medium
  • Google Site
  • Blogspot
  • API
  • Reddit
  • Tumblr
  • Scoop.it
  • Substack
  • Wordpress
  • Wix
  • Behance

© 2025 TheMediTary.Com All rights reserved. Operated by